The combined general meeting of Vétoquinol shareholders, which met on 22 May 2013, approved the appointment of Marie-Josèphe Baud as a new Board Director for a period of four years. Marie-Josèphe Baud is the head of a management consultancy and pharmaceutical strategy company. She began her career at Novartis (1971 to 1997), where she held several positions in market research, strategic planning and business development, prior to becoming Marketing Director, Marketing and Sales Director and Chief Executive Officer of the family healthcare unit.

She joined the Pharmacia Group (1997 to 2003) as Head of the Consumer Healthcare Division, and was then appointed Head of European Strategy. Between 2003 and 2007, Mrs. Baud was Vice President for Sales & Marketing at TEVA Europe and was appointed Chairwoman of the TEVA France Group in 2006. She was Chairwoman of Sandoz France (Novartis Group) between 2007 and 2010.